ALDH1A3 and breast carcinoma: This is consistent with breast cancer studies done by Marcato et al. (2011), who observed that ALDH1A3 knockdown was better correlated with a decrease in Aldefluor® activity compared to ALDH1A1 and ALDH2 [27].